What's breaking now, across thousands of outlets.
The big drugmaker’s latest company acquisition this year is centered around a technology designed to degrade proteins that malfunction in autoimmune disorders.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
"This study gives us an early indication that female biological systems respond differently to the unique conditions associated with space travel."
Early ECG monitoring initiated in the emergency department (ED) has the potential to transform the care of thousands of patients who visit the ED with unexplained fainting.
More than 40% of American women ages 40 and older have dense breast tissue, according to the National Cancer Institute. This type of tissue can make cancer harder to spot on mammograms and is itself…
The Food and Drugs Authority (FDA), in collaboration with the National Security, has seized quantities of unregistered cigarette-shaped candy being sold in the Central Business District (CBD) of…
Another hospital system sues CVS Health, how Medicaid cuts will change everything, and more
Bradley Bolivar is taking the reins of Centene’s IT strategy as artificial intelligence drives a sea change for how insurers do business.
